As the world becomes increasingly uncertain, Ventyx Biosciences Inc. (VTYX) offers stability

Ventyx Biosciences Inc. (NASDAQ: VTYX) closed the day trading at $34.87 up 2.11% from the previous closing price of $34.15. In other words, the price has increased by $+0.72 from its previous closing price. On the day, 1561257 shares were traded. VTYX stock price reached its highest trading level at $36.69 during the session, while it also had its lowest trading level at $33.66.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

Ratios:

For a better understanding of VTYX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.70 and its Current Ratio is at 11.70. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 19, 2022, initiated with a Buy rating and assigned the stock a target price of $50.

On November 17, 2022, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $45.

On September 07, 2022, Stifel started tracking the stock assigning a Buy rating and target price of $45.Stifel initiated its Buy rating on September 07, 2022, with a $45 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 22 when Mohan Raju sold 55,354 shares for $31.61 per share. The transaction valued at 1,749,640 led to the insider holds 1,603,126 shares of the business.

Nuss John sold 13,812 shares of VTYX for $436,654 on Dec 22. The Chief Scientific Officer now owns 244,815 shares after completing the transaction at $31.61 per share. On Dec 22, another insider, Krueger Christopher W, who serves as the Chief Business Officer of the company, sold 3,654 shares for $31.61 each. As a result, the insider received 115,518 and left with 282,670 shares of the company.

Stock Price History:

Over the past 52 weeks, VTYX has reached a high of $41.29, while it has fallen to a 52-week low of $9.50. The 50-Day Moving Average of the stock is 29.90, while the 200-Day Moving Average is calculated to be 23.06.

Shares Statistics:

Over the past 3-months, VTYX traded about 583.92K shares per day on average, while over the past 10 days, VTYX traded about 403.96k shares per day. A total of 51.67M shares are outstanding, with a floating share count of 50.91M. Insiders hold about 3.80% of the company’s shares, while institutions hold 99.70% stake in the company. Shares short for VTYX as of Oct 13, 2022 were 3.99M with a Short Ratio of 3.78M, compared to 3.5M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 7.06% and a Short% of Float of 14.33%.

Earnings Estimates

Current recommendations for the stock of the company come from 8 analysts. On average, analysts expect EPS of -$0.44 for the current quarter, with a high estimate of -$0.4 and a low estimate of -$0.51, while EPS last year was -$3.17. The consensus estimate for the next quarter is -$0.5, with high estimates of -$0.41 and low estimates of -$0.55.

Analysts are recommending an EPS of between -$1.65 and -$1.91 for the fiscal current year, implying an average EPS of -$1.79. EPS for the following year is -$2.17, with 8 analysts recommending between -$1.85 and -$2.7.